drugset / Trial / NCT00000650
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients
Completed
12 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
Connaught Laboratories · collab
Open-labelTreatment
Summary
To determine, in HIV-infected patients, the magnitude and duration of the biological effects of ditiocarb sodium (sodium diethyldithiocarbamate; DTC) that may be relevant to treatment of HIV infection. DTC has been studied in previous clinical trials in HIV-infected patients with the suggestion of delay in disease progression to AIDS and improvement in CD4 counts while on the drug.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 1996-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DITIOCARB | Small molecule | — | Intravenous |